¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ ±âÁ¸ ÀÎÇ÷翣ÀÚ Áø´Ü°Ë»ç¿Í µðÁöÅÐ Æǵ¶½Ã½ºÅÛÀ» °¡Áø 3°¡Áö ÀÎÇ÷翣ÀÚ Áø´Ü°Ë»ç ºñ±³
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

±âÁ¸ ÀÎÇ÷翣ÀÚ Áø´Ü°Ë»ç¿Í µðÁöÅÐ Æǵ¶½Ã½ºÅÛÀ» °¡Áø  3°¡Áö ÀÎÇ÷翣ÀÚ Áø´Ü°Ë»ç ºñ±³

(Comparison of three rapid influenza diagnostic tests with digital readout systems and one conventional rapid influenza diagnostic test)

 

ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º´Â A, B, CÇü À¸·Î ºÐ·ùµÇ¸ç, ¸Å³â À¯ÇàÇÏ´Â AÇü ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º´Â Ç¥¸éÇ׿øÀÎ Hemaglutinine (H1~H16)°ú Neuraminase (N1~N9)¿¡ ÀÇÇؼ­ ¾ÆÇüÀÌ °áÁ¤µÈ´Ù. ÀÎÇ÷翣ÀÚ A (H1N1) ¹ÙÀÌ·¯½º´Â 1918³â Á¶·ù·ÎºÎÅÍ »ç¶÷°ú µÅÁö¿¡°Ô ÀüÆÄµÇ¾î ´ëÀ¯ÇàÀ» ÀÏÀ¸Ä×°í, 1957³â »ç¶÷ ÀÎÇ÷翣ÀÚ A (H1N1) ¹ÙÀÌ·¯½º°¡ »ç¶óÁö°í, »ç¶÷ ÀÎÇ÷翣ÀÚ A (H2N2)°¡ ÃâÇöÇÏ¿´´Ù. 2009³â À¯¶ó½Ã¾Æ µÅÁö ÀÎÇ÷翣ÀÚ A (H1N1) ¹ÙÀÌ·¯½º¿Í ±âÁ¸ÀÇ 3Á¾ À¯ÀüÀÚ ÀçÆí¼º µÅÁö ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º °£¿¡ À¯ÀüÀÚ ÀçÆí¼ºÀÌ ÀϾ »õ·Î¿î ÇüÅÂÀÇ ¹ÙÀÌ·¯½º°¡ ³ªÅ¸³ª ÀÎÇ÷翣ÀÚ ´ëÀ¯ÇàÀ» ÀÏÀ¸Ä×´Ù. ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º´Â Ç׿øº¯À̸¦ ÅëÇØ À¯ÇàÀ» ÃÊ·¡Çϴµ¥, ÀϹÝÀûÀÎ °èÀý ÀÎÇ÷翣ÀÚ´Â Ç׿ø ¼Òº¯ÀÌ·Î ¸Å³â °Ü¿ï¿¡ Çѱ¹ÀÎÀ» ±«·ÓÈ÷°í ÀÖ´Ù.

 

2009³â 4¿ù ÀÌÈÄ Àü ¼¼°èÀûÀ¸·Î À¯ÇàÇÏ°í ÀÖ´Â ½ÅÁ¾ ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º(pandemic influenza H1N1 2009)´Â À¯ÀüÀÚ ÀçÁ¶ÇÕÀ¸·Î Ç׿ø ´ëº¯ÀÌ°¡ ÀϾ »õ·Î¿î ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º°¡ ¸¸µé¾îÁø °ÍÀÌ´Ù. Áúº´°ü¸®º»ºÎ¿¡ µû¸£¸é ÀÌ »õ·Î¿î ±ÕÁÖ´Â 2009-2010³â ÀÎÇ÷翣ÀÚ °¨¿°ÀÇ ´ë´Ù¼ö¸¦ ÀÏÀ¸Ä×°í, 2009 H1N1 ¹ÙÀÌ·¯½º°¡ µ¿½Ã¿¡ Àü¼¼°è¿¡ °ÉÃÄ ´Ù¼öÀÇ ÀÎÇ÷翣ÀÚ ¹ß¹ßÀ» ÀÏÀ¸Äױ⠶§¹®¿¡ ¼¼°èº¸°Ç±â±¸(WHO)´Â 2009 H1N1 ¹ÙÀÌ·¯½º¸¦ ¼¼°èÀû ´ëÀ¯Çà(pandemic)À¸·Î ¼±¾ðÇß´Ù. ÀÎÇ÷翣ÀÚ Áø´Ü°Ë»çÀÇ Å« 2°¡Áö È帧Àº ¨ç ¹ÙÀÌ·¯½º °ËÃâ°ú ¨è ¹ÙÀÌ·¯½º¿¡ ´ëÇÑ È¯ÀÚÀÇ ¸é¿ª¹ÝÀÀÀ» ÀÌ¿ëÇÑ ¹æ¹ýÀÌ ÁÖ¸¦ ÀÌ·ç°í ÀÖ´Ù. Áø´Ü°Ë»ç·Î´Â ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º ºÐ¸®(¹è¾ç), ¹ÙÀÌ·¯½º Ç׿ø(´Ü¹é)ÀÇ °ËÃâ(½Å¼ÓÇ׿ø°Ë»ç, ¸é¿ªÇü±¤¹ý), ¹ÙÀÌ·¯½º ÇÙ»êÀÇ ÀÔÁõ(RT-PCR), Ç÷ûÇÐÀû °Ë»ç µî 4°¡Áö·Î ´ëº°µÉ ¼ö ÀÖ´Ù. º» ¿¬±¸°æÇâ¿¡¼­´Â Àü ¼¼°èÀûÀ¸·Î À¯ÇàÇÏ°í ÀÖ´Â ½ÅÁ¾ ÀÎÇ÷翣ÀÚ¸¦ Æ÷ÇÔÇÏ¿©, ÀÎÇ÷翣ÀÚÀÇ Áø´Ü¿¡ ´ëÇؼ­ ±¹³»¿¡¼­ ±âÁ¸¿¡ º¸ÆíÀûÀ¸·Î »ç¿ëÇÏ°í ÀÖ´Â Rapid influenza diagnostic tests, RIDTs¿Í µðÁöÅÐ Æǵ¶½Ã½ºÅÛÀ» °¡Áø ½Å¼ÓÇÑ ÀÎÇ÷翣ÀÚ Áø´Ü°Ë»çµé(rapid influenza diagnostic tests with digital readout systems)À» ºñ±³ÇÏ¿´´Ù.

 

 

ÀÎÇ÷翣ÀÚ Áø´Ü°Ë»ç : ±âÁ¸ÀÇ ÀÎÇ÷翣ÀÚ Áø´ÜÅ×½ºÆ®¿Í µðÁöÅÐ Æǵ¶½Ã½ºÅÛÀ» °¡Áø  3°¡Áö ÀÎÇ÷翣ÀÚ Áø´Ü°Ë»ç ºñ±³ (Comparison of three rapid influenza diagnostic tests with digital readout systems and one conventional rapid influenza diagnostic test)

 

ÀÓ»óÁú¹®

±âÁ¸ÀÇ ½Å¼ÓÇÑ ÀÎÇ÷翣ÀÚ Áø´Ü°Ë»ç(Rapid influenza diagnostic tests, RIDTs)¿Í µðÁöÅÐÆǵ¶½Ã½ºÅÛÀ» °¡Áø ÀÎÇ÷翣ÀÚ Áø´Ü°Ë»çµé(rapid influenza diagnostic tests with digital readout systems)À» ºñ±³ÇßÀ» ¶§ ÀÎÇ÷翣ÀÚ Áø´ÜÀÇ Á¤È®µµ¿¡ Â÷ÀÌ°¡ ÀÖ½À´Ï±î?

±Ù°Å±â¹Ý´äº¯

µðÁöÅÐ Æǵ¶ ½Ã½ºÅÛÀ» °®Ãá RIDT´Â ±âÁ¸ÀÇ ½Å¼Ó Å×½ºÆ®º¸´Ù ³ôÀº °ËÃâ °¨µµ¸¦ ³ªÅ¸ ³»¾ú½À´Ï´Ù.

¼­ÁöÁ¤º¸

Comparison of three rapid influenza diagnostic tests with digital readout systems and one conventional rapid influenza diagnostic test (2018) J Clin Lab Anal. 32(2).

DOI: 10.1002/jcla.22234

Áúº´Æ¯¼º

ÀÎÇ÷翣ÀÚ H1N1

¿¬±¸¼³°è

Comparative Study

¿¬±¸´ë»ó

218: ½Å»ý¾Æ(neonates)~90¼¼±îÁö ³ëÀδë»ó ºñÀÎÈÄ ¸éºÀ(nasopharyngeal swabs)

Áø´Ü°Ë»ç

-µðÁöÅÐÆǵ¶ ½Ã½ºÅÛÀ» °¡Áø 3°¡Áö RIDTs: 1) BUDDI (NanoEnTek, Seoul, Korea), the Sofia Influenza A+B Fluorescence; 2) Immunoassay (Quidel,San Diego,CA,USA); 3) the BD Veritor System Flu A+B assay (BD Diagnostics, Sparks, MD, USA).

-±âÁ¸ ÀÎÇ÷翣ÀÚ °Ë»ç (A conventional rapid test; SD Bioline Influenza Ag A/B/A (H1N1/2009)

Æò°¡ÁöÇ¥

-The Anyplex Flu A/B Typing Real-time Detection real-time PCR

-ÀÎÇ÷翣ÀÚ ÇÏÀ§À¯Çü °ËÃâ ±¸º°´É·Â (Influenza subtype detection Capacity; Discrimination of influenza A and B)

-¹Î°¨µµ¿Í ƯÀ̵µ

»ó¼¼¼³¸í

-¼ÒÇǾƴ ÀÎÇ÷翣ÀÚ A ¹× B °ËÃâ¿¡ ´ëÇØ °¡Àå ³ôÀº °¨µµ¸¦ º¸¿´´Ù. BUDDI¿Í Veritor´Â ÀÎÇ÷翣ÀÚ A °ËÃâÀÇ °æ¿ì ±âÁ¸ÀÇ RIDTº¸´Ù ³ôÀº °ËÃâ °¨µµ¸¦ ³ªÅ¸³»Áö ¸¸ ÀÎÇ÷翣ÀÚ B °ËÃâÀÇ °æ¿ì À¯»çÇÑ °á°ú¸¦ º¸ÀÓ

-¹Î°¨µµ(sensitivity) °á°ú: BUDDI(92.1 %), Sofia(97.4 %), Veritor(94.7 %), ¹× Bioline(76.3 %)

-ƯÀ̵µ (specificity) °á°ú: BUDDI (100 %), Sofia(100 %), Veritor(97.4 %) ¹× Bioline (100 %)

±Ù°Å¼öÁØ

Moderate

ÀÛ¼ºÀÚ

ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC)

Copyright © 2015 Medical Research Information Center (MedRIC) Editors


 


2018-06-12 ¿ÀÈÄ 5:12:43, Á¶È¸¼ö : 2662